Phathom Pharmaceuticals, Inc. PHAT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Phathom Pharmaceuticals, Inc. (PHAT) reported deferred tax assets and other non-current assets of $3.09M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets increased by 82.4% year-over-year, from $1.69M to $3.09M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets has grown at a 50.0% compound annual growth rate (CAGR), from $384K to $2.92M.